A model for de novo synthesis and decomposition rates of dioxins and furans in municipal waste incinerators

1991 ◽  
Vol 104 (1-2) ◽  
pp. 35-46 ◽  
Author(s):  
S.S. Penner ◽  
C.P. Li ◽  
M.B. Richards ◽  
D.F. Wiesenhahn
Chemosphere ◽  
1989 ◽  
Vol 18 (1-6) ◽  
pp. 1219-1226 ◽  
Author(s):  
L. Stieglitz ◽  
G. Zwick ◽  
J. Beck ◽  
W. Roth ◽  
H. Vogg

2014 ◽  
Vol 48 (14) ◽  
pp. 7959-7965 ◽  
Author(s):  
Nuria Ortuño ◽  
Juan A. Conesa ◽  
Julia Moltó ◽  
Rafael Font

2016 ◽  
Vol 23 (2) ◽  
pp. 249-257 ◽  
Author(s):  
Grzegorz Wielgosiński ◽  
Olga Namiecińska ◽  
Patrycja Łechtańska ◽  
Adam Grochowalski

Abstract Polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans are generally considered the most dangerous chemical substances known to man. Although they have never been the product of purposeful human activity, yet they are formed in many chemical and virtually all thermal processes. Research on the occurrence of dioxins in the environment, their release into the environment, ways of formation and methods of reducing their emissions lasts since the late seventies of the last century. Currently, we know three basic pathways of dioxins formation in thermal processes, the most important of them being the so called de novo synthesis which occurs outside the combustion zone at 200-400°C in the presence of catalysts (eg copper) and oxygen from the products of incomplete combustion including carbon black and chlorine or chlorinated compounds. It is well known that some metals like copper catalyze the de novo synthesis, while others decompose dioxins and furans formed previously. The formation of dioxins resulting from the de novo synthesis was studied through analysis of the effect of the type of metal on the course of the de novo synthesis. The influence of the addition of sulfur, nitrogen and alkali metals on this synthesis was also examined because some reports in the literature refer to inhibitory effect of these elements.


1993 ◽  
Vol 70 (02) ◽  
pp. 273-280 ◽  
Author(s):  
Janos Kappelmayer ◽  
Satya P Kunapuli ◽  
Edward G Wyshock ◽  
Robert W Colman

SummaryWe demonstrate that in addition to possessing binding sites for intact factor V (FV), unstimulated peripheral blood monocytes also express activated factor V (FVa) on their surfaces. FVa was identified on the monocyte surface by monoclonal antibody B38 recognizing FVa light chain and by human oligoclonal antibodies H1 (to FVa light chain) and H2 (to FVa heavy chain) using immunofluorescence microscopy and flow cytometry. On Western blots, partially cleaved FV could be identified as a 220 kDa band in lysates of monocytes. In addition to surface expression of FVa, monocytes also contain intracellular FV as detected only after permeabilization by Triton X-100 by monoclonal antibody B10 directed specifically to the Cl domain not present in FVa. We sought to determine whether the presence of FV in peripheral blood monocytes is a result of de novo synthesis.Using in situ hybridization, no FV mRNA could be detected in monocytes, while in parallel control studies, factor V mRNA was detectable in Hep G2 cells and CD18 mRNA in monocytes. In addition, using reverse transcriptase and the polymerase chain reaction, no FV mRNA was detected in mononuclear cells or in U937 cells, but mRNA for factor V was present in Hep G2 cells using the same techniques. These data suggest that FV is present in human monocytes, presumably acquired by binding of plasma FV, and that the presence of this critical coagulation factor is not due to de novo synthesis.


1983 ◽  
Vol 49 (02) ◽  
pp. 069-072 ◽  
Author(s):  
U L H Johnsen ◽  
T Lyberg ◽  
K S Galdal ◽  
H Prydz

SummaryHuman umbilical vein endothelial cells in culture synthesize thromboplastin upon stimulation with phytohaemagglutinin (PHA) or the tumor promotor 12-O-tetradecanoyl-phorbol-13-acetate (TPA). The thromboplastin activity is further strongly enhanced in a time dependent reaction by the presence of gel-filtered platelets or platelet aggregates. This effect was demonstrable at platelet concentrations lower than those normally found in plasma, it may thus be of pathophysiological relevance. The thromboplastin activity increased with increasing number of platelets added. Cycloheximide inhibited the increase, suggesting that de novo synthesis of the protein component of thromboplastin, apoprotein III, is necessary.When care was taken to remove monocytes no thromboplastin activity and no apoprotein HI antigen could be demonstrated in suspensions of gel-filtered platelets, platelets aggregated with thrombin or homogenized platelets when studied with a coagulation assay and an antibody neutralization technique.


1971 ◽  
Vol 68 (1_Supplb) ◽  
pp. S135 ◽  
Author(s):  
R. S. Mathur ◽  
N. Wiqvist ◽  
E. Diczfalusy

Sign in / Sign up

Export Citation Format

Share Document